Avoiding Undertreatment, Overtreatment in Geriatric Breast Cancer Patients
This video reviews how to ensure that older breast cancer patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.
A paradox exists in the treatment of older breast cancer patients. This population has a higher risk of dying from their breast cancer and in many cases patients are being undertreated, as some can safely receive more effective treatments based on their specific disease characteristics.
But older patients also have a higher risk of dying from other causes compared with younger populations, and the risk of overtreatment is a serious consideration.
In this video, Hans Wildiers, MD, PhD, of University Hospitals Leuven in Belgium, discusses how to ensure that these patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.
Targeted Therapy First Strategy Reduces Need for Chemotherapy in Newly Diagnosed LBCL
December 7th 2025Lenalidomide, tafasitamab, rituximab, and acalabrutinib alone may allow 57% of patients with newly diagnosed LBCL to receive less than the standard number of chemotherapy cycles without compromising curative potential.
